406820 — BeautySkin Co Balance Sheet
0.000.00%
- KR₩47bn
- KR₩71bn
- KR₩81bn
- 26
- 56
- 19
- 22
Annual balance sheet for BeautySkin Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 2,289 | 6,806 | 7,868 | 4,735 | 14,681 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 4,770 | 7,739 | 11,070 | 24,618 | 17,100 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 10,071 | 25,753 | 25,464 | 38,116 | 40,485 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 15,556 | 22,904 | 21,909 | 21,863 | 25,929 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 26,246 | 67,606 | 64,485 | 74,235 | 82,994 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 14,784 | 34,660 | 28,329 | 37,228 | 38,751 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 15,739 | 38,276 | 31,780 | 39,143 | 48,893 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | 10,506 | 29,330 | 32,705 | 35,092 | 34,101 |
Total Liabilities & Shareholders' Equity | 26,246 | 67,606 | 64,485 | 74,235 | 82,994 |
Total Common Shares Outstanding |